PiggyBac is a prevalent transposon system used to deliver transgenes and functionally explore the mammalian untouched genomic territory. The important features of piggyBac transposon are the relatively low insertion site preference and the ability of seamless removal from genome, which allow its potential uses in functional genomics and regenerative medicine. Efforts to increase its transposition efficiency in mammals were made through engineering the corresponding transposase (PBase) codon usage to enhance its expression level and through screening for mutant PBase variants with increased enzyme activity. To improve the safety for its potential use in regenerative medicine applications, site-specific transposition was achieved by using engineered zinc finger- and Gal4-fused PBases. An excision-prone PBase variant has also been successfully developed. Here we describe the construction of a nucleolus-predominant PBase, NP-mPB, by adding a nucleolus-predominant (NP) signal peptide from HIV-1 TAT protein to a mammalian codon-optimized PBase (mPB). Although there is a predominant fraction of the NP-mPB-tGFP fusion proteins concentrated in the nucleoli, an insertion site preference toward nucleolar organizer regions is not detected. Instead a 3–4 fold increase in piggyBac transposition efficiency is reproducibly observed in mouse and human cells.
References
[1]
Mitra R, Fain-Thornton J, Craig NL (2008) piggyBac can bypass DNA synthesis during cut and paste transposition. EMBO J 27: 1097–1109. doi: 10.1038/emboj.2008.41
[2]
Liu X, Li N, Hu X, Zhang R, Li Q, et al. (2013) Efficient production of transgenic chickens based on piggyBac. Transgenic Res 22: 417–423. doi: 10.1007/s11248-012-9642-y
[3]
Rostovskaya M, Naumann R, Fu J, Obst M, Mueller D, et al. (2013) Transposon mediated BAC transgenesis via pronuclear injection of mouse zygotes. Genesis 51: 135–141. doi: 10.1002/dvg.22362
[4]
Zhang X, Xue R, Cao G, Hu X, Wang X, et al. (2012) Effects of egt gene transfer on the development of Bombyx mori. Gene 491: 272–277. doi: 10.1016/j.gene.2011.09.026
[5]
Su H, Liu X, Yan W, Shi T, Zhao X, et al. (2012) piggyBac transposon-mediated transgenesis in the apicomplexan parasite Eimeria tenella. PLoS One 7: e40075. doi: 10.1371/journal.pone.0040075
[6]
Martins S, Naish N, Walker AS, Morrison NI, Scaife S, et al. (2012) Germline transformation of the diamondback moth, Plutella xylostella L., using the piggyBac transposable element. Insect Mol Biol 21: 414–421. doi: 10.1111/j.1365-2583.2012.01146.x
[7]
Furushima K, Jang CW, Chen DW, Xiao N, Overbeek PA, et al. (2012) Insertional mutagenesis by a hybrid piggyBac and sleeping beauty transposon in the rat. Genetics 192: 1235–1248. doi: 10.1534/genetics.112.140855
[8]
Dubois E, Bischerour J, Marmignon A, Mathy N, Regnier V, et al. (2012) Transposon Invasion of the Paramecium Germline Genome Countered by a Domesticated PiggyBac Transposase and the NHEJ Pathway. Int J Evol Biol 2012: 436196. doi: 10.1155/2012/436196
[9]
O’Brochta DA, Alford RT, Pilitt KL, Aluvihare CU, Harrell RA 2nd (2011) piggyBac transposon remobilization and enhancer detection in Anopheles mosquitoes. Proc Natl Acad Sci U S A 108: 16339–16344. doi: 10.1073/pnas.1110628108
[10]
Nagy K, Sung HK, Zhang P, Laflamme S, Vincent P, et al. (2011) Induced pluripotent stem cell lines derived from equine fibroblasts. Stem Cell Rev 7: 693–702. doi: 10.1007/s12015-011-9239-5
[11]
Li J, Zhang JM, Li X, Suo F, Zhang MJ, et al. (2011) A piggyBac transposon-based mutagenesis system for the fission yeast Schizosaccharomyces pombe. Nucleic Acids Res 39: e40. doi: 10.1093/nar/gkq1358
[12]
Kim S, Saadeldin IM, Choi WJ, Lee SJ, Lee WW, et al. (2011) Production of transgenic bovine cloned embryos using piggybac transposition. J Vet Med Sci 73: 1453–1457. doi: 10.1292/jvms.11-0054
[13]
Crabb BS, de Koning-Ward TF, Gilson PR (2011) Toward forward genetic screens in malaria-causing parasites using the piggyBac transposon. BMC Biol 9: 21. doi: 10.1186/1741-7007-9-21
[14]
Wen H, Lan X, Zhang Y, Zhao T, Wang Y, et al. (2010) Transgenic silkworms (Bombyx mori) produce recombinant spider dragline silk in cocoons. Mol Biol Rep 37: 1815–1821. doi: 10.1007/s11033-009-9615-2
[15]
Warren IA, Fowler K, Smith H (2010) Germline transformation of the stalk-eyed fly, Teleopsis dalmanni. BMC Mol Biol 11: 86. doi: 10.1186/1471-2199-11-86
[16]
Chen YT, Furushima K, Hou PS, Ku AT, Deng JM, et al. (2010) PiggyBac transposon-mediated, reversible gene transfer in human embryonic stem cells. Stem Cells Dev 19: 763–771. doi: 10.1089/scd.2009.0118
[17]
Trauner J, Schinko J, Lorenzen MD, Shippy TD, Wimmer EA, et al. (2009) Large-scale insertional mutagenesis of a coleopteran stored grain pest, the red flour beetle Tribolium castaneum, identifies embryonic lethal mutations and enhancer traps. BMC Biol 7: 73. doi: 10.1186/1741-7007-7-73
[18]
Morales ME, Mann VH, Kines KJ, Gobert GN, Fraser MJ Jr, et al. (2007) piggyBac transposon mediated transgenesis of the human blood fluke, Schistosoma mansoni. FASEB J 21: 3479–3489. doi: 10.1096/fj.07-8726com
[19]
Wu SC, Meir YJ, Coates CJ, Handler AM, Pelczar P, et al. (2006) piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells. Proc Natl Acad Sci U S A 103: 15008–15013. doi: 10.1073/pnas.0606979103
[20]
Ding S, Wu X, Li G, Han M, Zhuang Y, et al. (2005) Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell 122: 473–483. doi: 10.1016/j.cell.2005.07.013
[21]
Gonzalez-Estevez C, Momose T, Gehring WJ, Salo E (2003) Transgenic planarian lines obtained by electroporation using transposon-derived vectors and an eye-specific GFP marker. Proc Natl Acad Sci U S A 100: 14046–14051. doi: 10.1073/pnas.2335980100
[22]
Ikadai H, Shaw Saliba K, Kanzok SM, McLean KJ, Tanaka TQ, et al. (2013) Transposon mutagenesis identifies genes essential for Plasmodium falciparum gametocytogenesis. Proc Natl Acad Sci U S A 110: E1676–1684. doi: 10.1073/pnas.1217712110
[23]
Schetelig MF, Handler AM (2013) Germline transformation of the spotted wing drosophilid, Drosophila suzukii, with a piggyBac transposon vector. Genetica 141: 189–193. doi: 10.1007/s10709-013-9717-6
[24]
Kim H, Kim K, Kim J, Kim SH, Yim J (2012) Mutagenesis by imprecise excision of the piggyBac transposon in Drosophila melanogaster. Biochem Biophys Res Commun 417: 335–339. doi: 10.1016/j.bbrc.2011.11.110
[25]
Rostovskaya M, Fu J, Obst M, Baer I, Weidlich S, et al. (2012) Transposon-mediated BAC transgenesis in human ES cells. Nucleic Acids Res 40: e150. doi: 10.1093/nar/gks643
[26]
Li MA, Turner DJ, Ning Z, Yusa K, Liang Q, et al. (2011) Mobilization of giant piggyBac transposons in the mouse genome. Nucleic Acids Res 39: e148. doi: 10.1093/nar/gkr764
[27]
Chen L, Stuart L, Ohsumi TK, Burgess S, Varshney GK, et al. (2013) Transposon activation mutagenesis as a screening tool for identifying resistance to cancer therapeutics. BMC Cancer 13: 93. doi: 10.1186/1471-2407-13-93
[28]
Huang Y, Pettitt SJ, Guo G, Liu G, Li MA, et al. (2012) Isolation of homozygous mutant mouse embryonic stem cells using a dual selection system. Nucleic Acids Res 40: e21. doi: 10.1093/nar/gkr908
[29]
You L, Chang D, Du HZ, Zhao YP (2011) Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells. Biochem Biophys Res Commun 407: 1–6. doi: 10.1016/j.bbrc.2011.02.027
[30]
Wang W, Hale C, Goulding D, Haslam SM, Tissot B, et al. (2011) Mannosidase 2, alpha 1 deficiency is associated with ricin resistance in embryonic stem (ES) cells. PLoS One 6: e22993. doi: 10.1371/journal.pone.0022993
[31]
Landrette SF, Cornett JC, Ni TK, Bosenberg MW, Xu T (2011) piggyBac transposon somatic mutagenesis with an activated reporter and tracker (PB-SMART) for genetic screens in mice. PLoS One 6: e26650. doi: 10.1371/journal.pone.0026650
[32]
Guo G, Huang Y, Humphreys P, Wang X, Smith A (2011) A PiggyBac-based recessive screening method to identify pluripotency regulators. PLoS One 6: e18189. doi: 10.1371/journal.pone.0018189
[33]
Rad R, Rad L, Wang W, Cadinanos J, Vassiliou G, et al. (2010) PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice. Science 330: 1104–1107. doi: 10.1126/science.1193004
[34]
Kong J, Wang F, Brenton JD, Adams DJ (2010) Slingshot: a PiggyBac based transposon system for tamoxifen-inducible ‘self-inactivating’ insertional mutagenesis. Nucleic Acids Res 38: e173. doi: 10.1093/nar/gkq658
[35]
Guo G, Smith A (2010) A genome-wide screen in EpiSCs identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency. Development 137: 3185–3192. doi: 10.1242/dev.052753
[36]
Albieri I, Onorati M, Calabrese G, Moiana A, Biasci D, et al. (2010) A DNA transposon-based approach to functional screening in neural stem cells. J Biotechnol 150: 11–21. doi: 10.1016/j.jbiotec.2010.07.027
[37]
Wang W, Bradley A, Huang Y (2009) A piggyBac transposon-based genome-wide library of insertionally mutated Blm-deficient murine ES cells. Genome Res 19: 667–673. doi: 10.1101/gr.085621.108
[38]
Galvan DL, Nakazawa Y, Kaja A, Kettlun C, Cooper LJ, et al. (2009) Genome-wide mapping of PiggyBac transposon integrations in primary human T cells. J Immunother 32: 837–844. doi: 10.1097/cji.0b013e3181b2914c
[39]
Sun LV, Jin K, Liu Y, Yang W, Xie X, et al. (2008) PBmice: an integrated database system of piggyBac (PB) insertional mutations and their characterizations in mice. Nucleic Acids Res 36: D729–734. doi: 10.1093/nar/gkm790
[40]
Wu S, Ying G, Wu Q, Capecchi MR (2007) Toward simpler and faster genome-wide mutagenesis in mice. Nat Genet 39: 922–930. doi: 10.1038/ng2060
[41]
Pettitt SJ, Rehman FL, Bajrami I, Brough R, Wallberg F, et al. (2013) A genetic screen using the PiggyBac transposon in haploid cells identifies Parp1 as a mediator of olaparib toxicity. PLoS One 8: e61520. doi: 10.1371/journal.pone.0061520
[42]
Di Matteo M, Belay E, Chuah MK, Vandendriessche T (2012) Recent developments in transposon-mediated gene therapy. Expert Opin Biol Ther 12: 841–858. doi: 10.1517/14712598.2012.684875
[43]
Meir YJ, Wu SC (2011) Transposon-based vector systems for gene therapy clinical trials: challenges and considerations. Chang Gung Med J 34: 565–579.
[44]
Meir YJ, Weirauch MT, Yang HS, Chung PC, Yu RK, et al. (2011) Genome-wide target profiling of piggyBac and Tol2 in HEK 293: pros and cons for gene discovery and gene therapy. BMC Biotechnol 11: 28. doi: 10.1186/1472-6750-11-28
[45]
Yang R, Jiang M, Kumar SM, Xu T, Wang F, et al. (2011) Generation of melanocytes from induced pluripotent stem cells. J Invest Dermatol 131: 2458–2466. doi: 10.1038/jid.2011.242
[46]
Yusa K, Rad R, Takeda J, Bradley A (2009) Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 6: 363–369. doi: 10.1038/nmeth.1323
[47]
Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, et al. (2009) piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458: 766–770. doi: 10.1038/nature07863
[48]
Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, et al. (2009) Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458: 771–775. doi: 10.1038/nature07864
[49]
Yusa K, Rashid ST, Strick-Marchand H, Varela I, Liu PQ, et al. (2011) Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells. Nature 478: 391–394. doi: 10.1038/nature10424
[50]
Cadinanos J, Bradley A (2007) Generation of an inducible and optimized piggyBac transposon system. Nucleic Acids Res 35: e87. doi: 10.1093/nar/gkm446
[51]
Ammar I, Gogol-Doring A, Miskey C, Chen W, Cathomen T, et al. (2012) Retargeting transposon insertions by the adeno-associated virus Rep protein. Nucleic Acids Res 40: 6693–6712. doi: 10.1093/nar/gks317
[52]
Kettlun C, Galvan DL, George AL Jr, Kaja A, Wilson MH (2011) Manipulating piggyBac transposon chromosomal integration site selection in human cells. Mol Ther 19: 1636–1644. doi: 10.1038/mt.2011.129
[53]
Mattis AN, Willenbring H (2012) A ZFN/piggyBac step closer to autologous liver cell therapy. Hepatology 55: 2033–2035. doi: 10.1002/hep.25715
[54]
Owens JB, Urschitz J, Stoytchev I, Dang NC, Stoytcheva Z, et al. (2012) Chimeric piggyBac transposases for genomic targeting in human cells. Nucleic Acids Res 40: 6978–6991. doi: 10.1093/nar/gks309
[55]
Moscou MJ, Bogdanove AJ (2009) A simple cipher governs DNA recognition by TAL effectors. Science 326: 1501. doi: 10.1126/science.1178817
[56]
Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, et al. (2009) Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326: 1509–1512. doi: 10.1126/science.1178811
[57]
Sanjana NE, Cong L, Zhou Y, Cunniff MM, Feng G, et al. (2012) A transcription activator-like effector toolbox for genome engineering. Nat Protoc 7: 171–192. doi: 10.1038/nprot.2011.431
[58]
Miller JC, Tan S, Qiao G, Barlow KA, Wang J, et al. (2011) A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 29: 143–148. doi: 10.1038/nbt.1755
[59]
Owens JB, Mauro D, Stoytchev I, Bhakta MS, Kim MS, et al. (2013) Transcription activator like effector (TALE)-directed piggyBac transposition in human cells. Nucleic Acids Res 41: 9197–9207. doi: 10.1093/nar/gkt677
[60]
Peitz M, Pfannkuche K, Rajewsky K, Edenhofer F (2002) Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc Natl Acad Sci U S A 99: 4489–4494. doi: 10.1073/pnas.032068699
[61]
Lee CY, Li JF, Liou JS, Charng YC, Huang YW, et al. (2011) A gene delivery system for human cells mediated by both a cell-penetrating peptide and a piggyBac transposase. Biomaterials 32: 6264–6276. doi: 10.1016/j.biomaterials.2011.05.012
[62]
Hauber J, Malim MH, Cullen BR (1989) Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J Virol 63: 1181–1187.
[63]
Ruben S, Perkins A, Purcell R, Joung K, Sia R, et al. (1989) Structural and functional characterization of human immunodeficiency virus tat protein. J Virol 63: 1–8.
[64]
McMahon AP, Bradley A (1990) The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 62: 1073–1085. doi: 10.1016/0092-8674(90)90385-r
[65]
Chen YT, Liu P, Bradley A (2004) Inducible gene trapping with drug-selectable markers and Cre/loxP to identify developmentally regulated genes. Mol Cell Biol 24: 9930–9941. doi: 10.1128/mcb.24.22.9930-9941.2004
[66]
Berry CC, de la Fuente JM, Mullin M, Chu SW, Curtis AS (2007) Nuclear localization of HIV-1 tat functionalized gold nanoparticles. IEEE Trans Nanobioscience 6: 262–269. doi: 10.1109/tnb.2007.908973
[67]
Vives E, Brodin P, Lebleu B (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272: 16010–16017. doi: 10.1074/jbc.272.25.16010
[68]
Edenhofer F (2008) Protein transduction revisited: novel insights into the mechanism underlying intracellular delivery of proteins. Curr Pharm Des 14: 3628–3636. doi: 10.2174/138161208786898833
[69]
Caron NJ, Quenneville SP, Tremblay JP (2004) Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins. Biochem Biophys Res Commun 319: 12–20. doi: 10.1016/j.bbrc.2004.04.180
[70]
Tunnemann G, Martin RM, Haupt S, Patsch C, Edenhofer F, et al. (2006) Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. FASEB J 20: 1775–1784. doi: 10.1096/fj.05-5523com
[71]
Yang Y, Ma J, Song Z, Wu M (2002) HIV-1 TAT-mediated protein transduction and subcellular localization using novel expression vectors. FEBS Lett 532: 36–44. doi: 10.1016/s0014-5793(02)03624-4
[72]
Caron NJ, Torrente Y, Camirand G, Bujold M, Chapdelaine P, et al. (2001) Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol Ther 3: 310–318. doi: 10.1006/mthe.2001.0279
[73]
Siomi H, Shida H, Maki M, Hatanaka M (1990) Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization. J Virol 64: 1803–1807.
[74]
Ponti D, Troiano M, Bellenchi GC, Battaglia PA, Gigliani F (2008) The HIV Tat protein affects processing of ribosomal RNA precursor. BMC Cell Biol 9: 32. doi: 10.1186/1471-2121-9-32
[75]
Li YP (1997) Protein B23 is an important human factor for the nucleolar localization of the human immunodeficiency virus protein Tat. J Virol 71: 4098–4102.
[76]
Marcello A, Lusic M, Pegoraro G, Pellegrini V, Beltram F, et al. (2004) Nuclear organization and the control of HIV-1 transcription. Gene 326: 1–11. doi: 10.1016/j.gene.2003.10.018
[77]
Li X, Burnight ER, Cooney AL, Malani N, Brady T, et al. (2013) piggyBac transposase tools for genome engineering. Proc Natl Acad Sci U S A 110: E2279–2287. doi: 10.1073/pnas.1305987110
[78]
Wei P, Garber ME, Fang SM, Fischer WH, Jones KA (1998) A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92: 451–462. doi: 10.1016/s0092-8674(00)80939-3
[79]
Das C, Edgcomb SP, Peteranderl R, Chen L, Frankel AD (2004) Evidence for conformational flexibility in the Tat-TAR recognition motif of cyclin T1. Virology 318: 306–317. doi: 10.1016/j.virol.2003.10.003
[80]
De Luca A, De Falco M, Baldi A, Paggi MG (2003) Cyclin T: three forms for different roles in physiological and pathological functions. J Cell Physiol 194: 101–107. doi: 10.1002/jcp.10196
[81]
Fraldi A, Licciardo P, Majello B, Giordano A, Lania L (2001) Distinct regions of cyclinT1 are required for binding to CDK9 and for recruitment to the HIV-1 Tat/TAR complex. J Cell Biochem Suppl Suppl 36: 247–253.
[82]
Yusa K, Zhou L, Li MA, Bradley A, Craig NL (2011) A hyperactive piggyBac transposase for mammalian applications. Proc Natl Acad Sci U S A 108: 1531–1536. doi: 10.1073/pnas.1008322108
